% Expired Patents = 75.0

CIPO Patents = 2

Forward Citations = 29

Loading Chart...

8 inventors (with patents filed for the assignee):

Carl Thomas Wild (4 out of 19 patents)

Graham P Allaway (3 out of 21 patents)

Eric O Freed (1 out of 3 patents)

4. Feng Li (1 out of 3 patents)

5. Kuo-Hsiung Lee (1 out of 56 patents)

6. Karl Salzwedel (1 out of 2 patents)

7. Yoshiki Kashiwada (1 out of 6 patents)

8. Carol D Weiss (1 out of 1 patent)

9. Robert E Kilkuskie (3 patents)

10. Mark Manak (5 patents)

11. Mark Cosentino (4 patents)

12. Louis Mark Cosentino (3 patents)

13. Jing-Xi Xie (1 patent)

14. Kuo-Hsiung Lee (0 patent)

15. Lan Xie (0 patent)

4 patents: Sort by Forward Citations

1. 7537765 - Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein (2009-05-26),

2. 7365221 - Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof (2008-04-29),

3. 7311916 - Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41 (2007-12-25),

4. 6605427 - Assay for detection of viral fusion inhibitors (2003-08-12),

Panacos Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative antiviral therapeutics for the treatment of HIV/AIDS. The company's lead product candidate, bevirimat, is a novel HIV maturation inhibitor that holds promise as a potential new treatment option for individuals living with HIV. Panacos is committed to advancing the field of antiviral drug development and improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#87 in Gaithersburg, MD

#895 in Maryland

#60,561 in US

Gaithersburg, MD, United States of America

Panacos Pharmaceuticals, Inc.